about
The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 ReactivationCase Characterization, Clinical Features and Risk Factors in Drug-Induced Liver InjuryScientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United StatesChronic treatment with fluphenazine alters parameters of oxidative stress in liver and kidney of ratsDrug-induced liver injury: recent advances in diagnosis and risk assessment.Alcoholic liver disease: a synopsis of the Charles Lieber's Memorial Symposia 2009-2012.Evaluation of drug-induced serious hepatotoxicity (eDISH): application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery.Hy's law.An integrated analysis of liver safety data from orlistat clinical trials.Evolution of the Food and Drug Administration approach to liver safety assessment for new drugs: current status and challenges.Various forms of chemically induced liver injury and their detection by diagnostic proceduresMonitoring for hepatotoxicity: what is the predictive value of liver "function" tests?Alanine aminotransferase: a clinical and regulatory tool for detecting liver injury-past, present, and future.Predicting possible zonisamide hypersensitivity syndrome.Hepatotoxicity of New Oral Anticoagulants (NOACs).Recent advances in biomarkers and therapeutic interventions for hepatic drug safety - false dawn or new horizon?Halothane hepatitis. Current concepts.Application and results of whole-body autoradiography in distribution studies of organic solvents.Phenylbutazone liver injury: a clinical-pathologic survey of 23 cases and review of the literature.Induction of carcinomas in the nasal cavity of rats by dioxaneUsing controlled clinical trials to learn more about acute drug-induced liver injury.Multiple halothane exposure and hepatic bromsulphthalein clearance.Drug-induced liver injury in Oncology.Effect of repeated administration of berenil on urinary enzyme excretion with corresponding tissue pattern in rats.
P2860
Q21284983-85ACD39B-3826-4167-893A-1C28804E416AQ26749054-25BC33F6-6FDD-444B-A3D1-455328305647Q26767376-C84A5B95-FA52-4930-ADD8-6FBB8908B61BQ28580372-C5573B4D-968A-4355-9EFF-D1092EB43437Q30235089-69A2FA4F-5E76-44BF-9C95-F6BACF7B8C15Q33813166-FBAA8D75-082B-4E2D-8536-D35484FF8820Q33823899-86E1E177-EFB7-4CEB-9F31-A7F8A321B7E3Q34295400-A662A9D9-80DD-44F4-AE35-2EA730DCFA59Q34362116-490E8759-BBE7-40CB-86CA-35580EB86B6AQ34417044-4FA9F3EE-BA34-45E7-8C42-3AB5CC1A3C2BQ34663581-1671E3C2-49E3-4664-A52E-B50BD2FF39D4Q37364425-F1442DCD-DE28-4A06-A3E4-3AC874EE2B2EQ38032729-494110AC-28A2-4488-B682-0A4F35B7CC08Q38476341-350533F5-D06B-43C5-A1AA-EDBBBDB1216FQ38542198-9E2D31EA-9561-4CBF-92B9-8BAEBA05F6CEQ38753644-B097E825-0D93-4C59-A56E-4E1B08CFB771Q39881563-CE31FDB8-ACD2-40A4-9E7D-6A0A7372A42BQ40165971-674BA6C4-305E-4AFF-8638-0B6C26243421Q40355330-3E0076FD-4397-4AA1-AB84-C826E2D88215Q41430191-BF21BBE7-9C97-431B-B222-E0CF45D9BCC8Q45833400-F85A91A5-048D-4E26-9917-DBF77EEE7385Q49369306-B95FEE30-29E1-4CF3-954B-C27385E8621BQ50662188-8FA4EE5B-731D-4295-B208-E9F844402483Q50690286-CC4FFB1C-1E02-4197-8929-E5F473048396
P2860
description
1968 nî lūn-bûn
@nan
1968年の論文
@ja
1968年学术文章
@wuu
1968年学术文章
@zh
1968年学术文章
@zh-cn
1968年学术文章
@zh-hans
1968年学术文章
@zh-my
1968年学术文章
@zh-sg
1968年學術文章
@yue
1968年學術文章
@zh-hant
name
The spectrum of hepatotoxicity.
@en
The spectrum of hepatotoxicity.
@nl
type
label
The spectrum of hepatotoxicity.
@en
The spectrum of hepatotoxicity.
@nl
prefLabel
The spectrum of hepatotoxicity.
@en
The spectrum of hepatotoxicity.
@nl
P356
P1476
The spectrum of hepatotoxicity.
@en
P2093
H J Zimmerman
P304
P356
10.1353/PBM.1968.0004
P577
1968-01-01T00:00:00Z